| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036062472 |
| P356 | DOI | 10.1007/S40272-016-0175-3 |
| P698 | PubMed publication ID | 27139496 |
| P50 | author | David T Teachey | Q82889836 |
| P2093 | author name string | Lindsey A George | |
| P2860 | cites work | Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations | Q22254363 |
| Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage | Q24603171 | ||
| Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome | Q24623046 | ||
| Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) | Q24623371 | ||
| Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop | Q24632569 | ||
| How I treat autoimmune lymphoproliferative syndrome | Q24633207 | ||
| Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome | Q24650472 | ||
| Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS) | Q24685850 | ||
| Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy | Q27183550 | ||
| The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity | Q28139188 | ||
| Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency | Q28204372 | ||
| Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations | Q28210645 | ||
| A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome | Q28215936 | ||
| FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome | Q28235519 | ||
| The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency | Q40832724 | ||
| Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience. | Q41172796 | ||
| Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency | Q42664067 | ||
| Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs | Q43977140 | ||
| Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis | Q44455328 | ||
| IL-17 protects T cells from apoptosis and contributes to development of ALPS-like phenotypes. | Q45115236 | ||
| Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS). | Q46908424 | ||
| Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness. | Q50755650 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome | Q28239313 | ||
| A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation | Q28246980 | ||
| Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome | Q28248908 | ||
| Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations | Q28250000 | ||
| Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations | Q28250725 | ||
| Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations | Q28263161 | ||
| Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study | Q28270195 | ||
| Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 | Q28284177 | ||
| Autoimmune lymphoproliferative syndrome with somatic Fas mutations | Q28285625 | ||
| Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) | Q28293136 | ||
| FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function | Q28307801 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias. | Q33375562 | ||
| Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans' syndrome | Q33377012 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Clinical, immunological, and pathological consequences of Fas-deficient conditions | Q33496872 | ||
| A human immunodeficiency caused by mutations in the PIK3R1 gene | Q34129000 | ||
| Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. | Q34148939 | ||
| Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis | Q34149957 | ||
| New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome | Q34239719 | ||
| Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency | Q34380652 | ||
| Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling | Q34391120 | ||
| Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation | Q34428954 | ||
| Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K | Q34452767 | ||
| New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children | Q34890377 | ||
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. | Q35132088 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| Caspase-8 Deficiency Presenting as Late-Onset Multi-Organ Lymphocytic Infiltration with Granulomas in two Adult Siblings | Q35629669 | ||
| NRAS mutation causes a human autoimmune lymphoproliferative syndrome. | Q35829141 | ||
| Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial | Q36443121 | ||
| Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells | Q37209943 | ||
| Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations | Q37670054 | ||
| Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome | Q38442307 | ||
| Spectrum of Phenotypes Associated with Mutations in LRBA. | Q38680451 | ||
| P433 | issue | 4 | |
| P921 | main subject | autoimmune lymphoproliferative syndrome | Q1151300 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 261-272 | |
| P577 | publication date | 2016-04-30 | |
| P1433 | published in | Pediatric Drugs | Q15767256 |
| P1476 | title | Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children | |
| P478 | volume | 18 |
Search more.